B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ALOX15B

MOLECULAR TARGET

arachidonate 15-lipoxygenase type B

UniProt: O15296NCBI Gene: 24715 compounds

ALOX15B (arachidonate 15-lipoxygenase type B) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ALOX15B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Quercetin1.102
2Ethoxyquin Antioxidant; also1.102
3Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
4alpha-Linolenic Acid0.691
5Aurintricarboxylic Acid0.691
6Dipyrone0.691
7ethopropazine hydrochloride0.691
8Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone0.691
9Hexachlorophene0.691
10juglone hydroxylase [Supplementary Concept] catalyzes0.691
11ninhydrin0.691
12Masoprocol0.691
13piceatannol0.691
14Pseudoephedrine0.691
15Troglitazone0.691

About ALOX15B as a Drug Target

ALOX15B (arachidonate 15-lipoxygenase type B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented ALOX15B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ALOX15B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.